Literature DB >> 287328

Inflammatory middle ear diseases in patients with cystic fibrosis.

K Bak-Pedersen, P K Larsen.   

Abstract

111 patients with cystic fibrosis (CF), aged 7 months to 29 years, were examined to detect inflammatory middle ear diseases. 35% had a history of one or more attacks of acute otitis media, an incidence at the same level as in non-CF patients. None had chronic suppurative otitis. Only 4 out of the 88 patients able to cooperate in audiometry had a hearing impairment. In 2, the hearing loss was perceptive, in 3 very mild, and in the fourth case, moderately severe. The middle ear pressure was measured in 108 patients, in 86 of whom it proved normal. In 15 patients the middle ear pressure was lower than--100 mmH2O, indicating tubal occlusion, and in 7 patients the impedance minimum was lacking, indicating an accumulation of mucus. These 7 patients (6%) had secretory otitis media. Nasal polyps were or had been present in 32%. There was no correlation between nasal polyps and tubal occlusion or secretory otitis. The incidence of inflammatory middle ear diseases in CF patients was in the same range as in non-CF patients, a finding at variance with some previous investigations showing middle ear pathology in 25--48%.

Entities:  

Mesh:

Year:  1979        PMID: 287328     DOI: 10.3109/00016487809123499

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  7 in total

Review 1.  ENT surgery and cystic fibrosis.

Authors:  A R Maw
Journal:  J R Soc Med       Date:  1992       Impact factor: 5.344

Review 2.  Upper respiratory disease, sinusitis, and polyposis.

Authors:  V V King
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

Review 3.  Nasal polyposis, opaque paranasal sinuses and usually normal hearing: the otorhinolaryngological features of cystic fibrosis.

Authors:  T J David
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

Review 4.  Sinusitis in patients with cystic fibrosis.

Authors:  Y Hui; R Gaffney; W S Crysdale
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

5.  Ear disease is not a common complication in cystic fibrosis.

Authors:  M Cipolli; M Canciani; M Cavazzani; P Uras; P Zampieri; G Mastella
Journal:  Eur J Pediatr       Date:  1993-03       Impact factor: 3.183

6.  Functional Impacts of Aminoglycoside Treatment on Speech Perception and Extended High-Frequency Hearing Loss in a Pediatric Cystic Fibrosis Cohort.

Authors:  Chelsea M Blankenship; Lisa L Hunter; M Patrick Feeney; Madison Cox; Lindsey Bittinger; Angela C Garinis; Li Lin; Gary McPhail; John P Clancy
Journal:  Am J Audiol       Date:  2021-01-19       Impact factor: 1.636

7.  Otitis media prone children with cystic fibrosis: A new normal.

Authors:  Jennifer L McCoy; Thomas M Kaffenberger; Tiffany S Yang; Joseph E Dohar
Journal:  Am J Otolaryngol       Date:  2021-06-19       Impact factor: 2.873

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.